Article
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
5 Nov 2021
Abstract excerpt
BACKGROUND: Soft-tissue sarcomas (STS) represent a heterogeneous group of rare tumors including more than 70 different histological subtypes. High throughput molecular analysis (next generation sequencing exome [NGS]) is a unique opportunity to identify driver mutations that can change the usual one-size-fits-all treatment paradigm to a patient-driven therapeutic strategy. The primary objective of the MULTISARC...
Topics
Join the communities discussing this publication.